# Biogen Inc.: Form 8-K/A, filed Jun 10, 2026

- Company: [Biogen Inc.](/companies/biib.md) (CIK 875045)
- Form: 8-K/A
- Filed: 2026-06-10
- Accepted by EDGAR: Jun 10, 2026, 16:49 ET
- Period: 2026-05-14
- Accession: 0000950157-26-000699
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875045/000095015726000699/form8-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875045/000095015726000699/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875045/000095015726000699/form8-ka.htm

Filed Jun 10, 2026.
Source: SEC EDGAR, the filing index for accession 0000950157-26-000699. Last ingested by Listed: Nov 2, 2026, 20:22 ET. No prices; not investment advice.